[1]
“Re-evaluating Immediate, Adjuvant, and Salvage Intravesical Chemotherapy in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Gemcitabine Non-Inferiority to Mitomycin C”, AMCR, vol. 7, no. 2, pp. 188–212, Mar. 2026, doi: 10.37275/amcr.v7i2.863.